Results 1 to 10 of about 16,734 (157)

Advances in the multifunctional roles of CX3CL1 in the central nervous system [PDF]

open access: yesFrontiers in Aging Neuroscience
C-X3-C motif chemokine ligand 1 (CX3CL1), a structurally unique chemokine in the central nervous system (CNS), shapes physiological and pathological processes via specific binding to its receptor, C-X3-C motif chemokine receptor 1 (CX3CR1).
Yuhui Chen   +15 more
doaj   +2 more sources

An overview of the role of chemokine CX3CL1 (Fractalkine) and CX3C chemokine receptor 1 in systemic sclerosis [PDF]

open access: yesImmunity, Inflammation and Disease
Introduction Systemic sclerosis (SSc) is a complex autoimmune disease characterized by fibrosis, vascular damage, and immune dysregulation. Fractalkine or chemokine (C‐X3‐C motif) ligand 1 (CX3CL1), a chemokine and adhesion molecule, along with its ...
Fatemehsadat Pezeshkian   +2 more
doaj   +2 more sources

The chemokine CX3CL1 promotes intraperitoneal tumour growth despite enhanced T-cell recruitment in ovarian cancer [PDF]

open access: yesNeoplasia: An International Journal for Oncology Research
T-cell recruiting chemokines are required for a successful immune intervention in ovarian cancer, and also for the efficacy of modern anticancer agents such as PARP inhibitors.
Stefanie Seitz   +13 more
doaj   +2 more sources

Glycosaminoglycan binding to soluble CX3CL1 impacts monocyte migration in vitro [PDF]

open access: yesFrontiers in Immunology
IntroductionIn addition to providing shear-resistant cell-cell adhesion in its natural membrane-bound form, the soluble variant of CX3CL1 (or fractalkine) promotes strong cell migration through signaling via its unique G-protein-coupled receptor CX3CR1 ...
Maria Ennemoser   +8 more
doaj   +2 more sources

CCL2/CCR2 and CX3CL1/CX3CR1 chemokine axes and their possible involvement in age-related macular degeneration [PDF]

open access: yesJournal of Neuroinflammation, 2010
The causes of age-related macular degeneration (AMD) are not well understood. Due to demographic shifts in the industrialized world a growing number of people will develop AMD in the coming decades.
Camelo Serge   +6 more
doaj   +5 more sources

Diagnostic potential of urinary CX3CL1 for amnestic mild cognitive impairment and Alzheimer’s disease [PDF]

open access: yesFrontiers in Aging Neuroscience
IntroductionThe role of the chemokine CX3CL1 in the processes of aging and Alzheimer’s disease (AD) pathogenesis is well-established. This study aims to evaluate the diagnostic potential of urinary CX3CL1 levels in distinguishing between AD patients ...
Yali Xu   +8 more
doaj   +2 more sources

CX3CL1 deficiency ameliorates acute kidney injury by inhibiting macrophage mitochondrial dysfunction and mtDNA-cGAS-STING signaling [PDF]

open access: yesCell Death Discovery
Dysregulated mitochondrial dynamics and macrophage-driven inflammation are essential contributors to the pathogenesis of acute kidney injury (AKI).
Qiming Gong   +8 more
doaj   +2 more sources

Structural basis of chemokine sequestration by CrmD, a poxvirus-encoded tumor necrosis factor receptor. [PDF]

open access: yesPLoS Pathogens, 2011
Pathogens have evolved sophisticated mechanisms to evade detection and destruction by the host immune system. Large DNA viruses encode homologues of chemokines and their receptors, as well as chemokine-binding proteins (CKBPs) to modulate the chemokine ...
Xiaoguang Xue   +8 more
doaj   +1 more source

Enhanced recruitment of genetically modified CX3CR1-positive human T cells into Fractalkine/CX3CL1 expressing tumors: importance of the chemokine gradient. [PDF]

open access: yes, 2016
BACKGROUND: Adoptive T-cell based immunotherapies constitute a promising approach to treat cancer, however, a major problem is to obtain effective and long-lasting anti-tumor responses.
Allavena, P.   +4 more
core   +11 more sources

Implications of fractalkine on glial function, ablation and glial proteins/receptors/markers—understanding its therapeutic usefulness in neurological settings: a narrative review

open access: yesFuture Journal of Pharmaceutical Sciences, 2022
Background Fractalkine (CX3CL1) is a chemokine predominantly released by neurons. As a signaling molecule, CX3CL1 facilitates talk between neurons and glia. CX3CL1 is considered as a potential target which could alleviate neuroinflammation.
Deepraj Paul, Duraiswamy Basavan
doaj   +1 more source

Home - About - Disclaimer - Privacy